Medical Device News Magazine

Unveiling a Visionary Leader: Dr A Burton Tripathi Assumes CEO Role at Beyeonics

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Dr A Burton Tripathi

Beyeonics Vision Ltd., a pioneering MedTech company in the field of digital surgical platforms for imaging during ophthalmic procedures, announces the appointment of Burton Tripathi, PhD, as its new Chief Executive Officer. This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.

Experience

Dr. Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.

New Role Responsibilities

In his new role as CEO of Beyeonics Vision, Dr. Tripathi will lead the company’s strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.

Yoram Shmuely, Chairman of the Beyeonics Vision Board

“We believe Mr. Tripathi’s leadership will continue to drive innovation and push forward Beyeonics Vision into the market. His appointment reflects our dedication to delivering cutting-edge solutions that enhance patient care. We also extend our gratitude to Mr. Ron Schnieder for his leadership in recent years, and we look forward to his continued contributions as a board member.”

Dr. Tripathi

“I am honored to be appointed as CEO of Beyeonics Vision. The company has an impressive portfolio of advanced technology and a talented team of employees. Together we are committed to building on the company’s groundbreaking innovation and advancing our mission to transform patient care in Ophthalmology”, Dr. Tripathi shared.

A leading figure in the transformation of surgical visualization from analog to digital, Dr. Tripathi, author of over 30 patents, has been instrumental in the adoption of digital imaging technology across all types of microsurgery. Dr. Tripathi has a Doctorate from the California Institute of Technology and a Bachelor’s from Cornell University both in Mechanical Engineering. He began his career at McKinsey & Company, followed by advancing leadership roles with Intuitive Surgical, Allergan, and Alcon.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”